SCHEMBL18853501

SCHEMBL18853501

CC1(C)c2cc3ccccc3cc2-c2cnc(-c3ccccc3)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ KMT2A Q03164 4/20 0.37
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ HPGDS O60760 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19008925 0.80 ADORA2A (0.36) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL19008890 0.80 L3MBTL1 (0.39) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL18853088 0.80 EGFR (0.39) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL19008882 0.80 L3MBTL1 (0.36) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL19008884 0.79 MEN1 (0.43) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL19008853 0.78 MEN1 (0.42) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL18853640 0.77 SMN1; SMN2 (0.48) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL19008916 0.77 ADORA2A (0.35) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL17886469 0.77 MEN1 (0.35) MAPTSMN1; SMN2LMNAKMT2AALDH1A1
SCHEMBL19008936 0.77 NPC1 (0.34) MAPTNPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 MAPT 1935/4885NPC1 741/4885RAB9A 3530/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 MAPT 1935/4885NPC1 741/4885RAB9A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback